Your browser doesn't support javascript.
loading
The risk of PD-L1 expression misclassification in triple-negative breast cancer.
Ben Dori, Shani; Aizic, Asaf; Zubkov, Asia; Tsuriel, Shlomo; Sabo, Edmond; Hershkovitz, Dov.
Affiliation
  • Ben Dori S; B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Aizic A; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel.
  • Zubkov A; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel.
  • Tsuriel S; Institute of Pathology, Tel-Aviv Sourasky Medical Center, Dafna 5, 6492601, Tel Aviv, Israel.
  • Sabo E; B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Hershkovitz D; Institute of Pathology, Carmel Medical Center, Haifa, Israel.
Breast Cancer Res Treat ; 194(2): 297-305, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35622241
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article Affiliation country: Israel
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Triple Negative Breast Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Breast Cancer Res Treat Year: 2022 Type: Article Affiliation country: Israel